Company Encyclopedia
View More
name
BURCON NUTRASCIENCE CORP
BRCND.US
450.40 B
BRCND.USMarket value -Rank by Market Cap -/-

Financial Score

30/12/2025 Update
D
Specialty ChemicalsIndustry
Industry Ranking45/47
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-136.64%E
    • Profit Margin-2166.98%E
    • Gross Margin-228.31%E
  • Growth ScoreA
    • Revenue YoY98.16%A
    • Net Profit YoY-6.32%C
    • Total Assets YoY124.64%A
    • Net Assets YoY27.48%A
  • Cash ScoreB
    • Cash Flow Margin-4.61%D
    • OCF YoY98.16%A
  • Operating ScoreE
    • Turnover0.02E
  • Debt ScoreE
    • Gearing Ratio77.35%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Burcon Highlights Strong Year of Execution and Commercial Momentum in Shareholder Letter

    Burcon NutraScience Corporation issued a shareholder letter highlighting a strong year of execution and commercial momentum in 2025. The company reported significant revenue growth driven by high demand for its plant-based protein products. Burcon expects 2025 revenue to be $1-3 million and aims for over $10 million in 2026. The company has validated its protein technologies at a commercial scale and is making targeted production investments to meet rising demand. Burcon is finalizing financing to support growth and aims to achieve positive cash flow in 2026.

    Newsfile Corp.·
    US
    BRCNF
    -3.85%
    US
    BRCND
    0.00%
    Newsfile Corp.·
    US
    BRCNF
    -3.85%
    US
    BRCND
    0.00%

    Stonegate Capital Partners Updates Coverage on Burcon Nutrascience Corporation (BU) FY26 Q2

    Stonegate Capital Partners has updated its coverage on Burcon Nutrascience Corporation for FY26 Q2. Burcon achieved first commercial production and sales of Puratein® C canola protein and FavaPro fava protein, and scaled Peazazz® C pea protein. The company generated $0.36M in revenues, a 783% increase from the previous year, and received over $500,000 in commercial sales orders. Financing was strengthened by $4.0M in unsecured convertible debentures and a $0.7M short-term loan.

    Newsfile Corp.·
    US
    BRCND
    0.00%
    Newsfile Corp.·
    US
    BRCND
    0.00%

    Burcon NutraScience Announces $4 Million Private Placement of Convertible Debentures

    Burcon NutraScience Corporation has announced a non-brokered private placement of convertible debentures totaling up to $4 million, with insiders committing at least $2 million. The offering requires approval from the Toronto Stock Exchange and the securities are not registered under the U.S. Securities Act of 1933, thus cannot be sold in the U.S. without an exemption.

    Reuters·
    US
    BRCNF
    -3.85%
    Reuters·
    US
    BRCNF
    -3.85%

    Burcon Pea and Sunflower Proteins Outperform in Plant-based Cheese Study

    Burcon NutraScience Corporation announced that its Peazazz®C pea protein and Solatein™ sunflower protein significantly outperform a leading competitor's pea protein in a study by the University of Guelph for plant-based cheese applications. The proteins demonstrated superior texture and sensory properties, achieving dairy-like melt and stretch. Both proteins are clean-label, hypoallergenic, and non-GMO, supporting Burcon's commitment to sustainability and innovation in the plant-based market. This study validates Burcon's technology platform and opens new commercial opportunities in the dairy-alternative sector.

    Newsfile Corp.·
    US
    BRCNF
    -3.85%
    US
    BRCND
    0.00%
    Newsfile Corp.·
    US
    BRCNF
    -3.85%
    US
    BRCND
    0.00%

    Burcon Announces New Board Members and Results of Shareholder Meeting | BRCNF Stock News

    Burcon NutraScience Corporation has appointed Philip Dowad and Richard Nazur Jr. to its Board of Directors, enhancing its leadership as it enters a new growth phase. The company also reported the results of its 2025 annual general meeting, where all seven director nominees were elected. Shareholders approved KPMG LLP as auditors and amended the exercise price of outstanding warrants. Dowad brings extensive experience in securities regulation, while Nazur has over 20 years in agricultural commodity markets. Burcon specializes in plant-based protein innovation, holding a significant patent portfolio.

    StockTitan·
    US
    BRCNF
    -3.85%
    StockTitan·
    US
    BRCNF
    -3.85%
    © 2025 Longbridge｜Disclaimer